Literature DB >> 11113634

Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons.

B S Basavarajappa1, M Saito, T B Cooper, B L Hungund.   

Abstract

In an earlier study, we reported that chronic ethanol (EtOH) stimulates the formation of anandamide in human SK-N-SH cells. In the present study, we investigated the effect of chronic EtOH on the formation of yet another cannabinoid receptor (CB1) agonist, 2-arachidonylglycerol (2-AG), in cerebellar granule neurons (CGNs). The formation of 2-[(3)H]AG without any stimulation was more pronounced in the older cultures than in younger cultures. Exposure of CGNs to EtOH led to a significant increase in the level of 2-[(3)H]AG (P<0.05). Incubation with the anandamidehydrolase inhibitor phenylmethylsulfonyl fluoride and EtOH did result in an additive increase in 2-[(3)H]AG, but did not with E-6-(bromomethylene)tetrahydro-3-(1-naphthelenyl)-2H-pyran-2-one. The formation of 2-[(3)H]AG was enhanced by ionomycin in both the control and EtOH-exposed CGNs, and the ionomycin-stimulated 2-[(3)H]AG synthesis was inhibited by the intracellular chelating agent 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid. Further, glutamate increased the formation of 2-[(3)H]AG only in control CGNs. MK-801 inhibited the EtOH-induced 2-[(3)H]AG synthesis, suggesting the participation of intracellular Ca(2+) in EtOH-induced 2-[(3)H]AG synthesis. The dopamine receptor (D2) agonist did not modify the 2-AG synthesis in either the control or EtOH-exposed CGNs. However, the D2 receptor antagonist inhibited the EtOH-induced formation of 2-[(3)H]AG. The EtOH-induced 2-[(3)H]AG formation was inhibited by SR141716A and pertussis toxin, suggesting the CB1 receptor- and Gi/o-protein-mediated regulation of 2-AG. The observed increase in 2-AG level in CGNs is possibly a mechanism for neuronal adaptation to the continuous presence of EtOH. These findings indicate that some of the pharmacological actions of EtOH may involve alterations in the endocannabinoid signaling system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113634     DOI: 10.1016/s0925-4439(00)00085-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  41 in total

1.  Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.

Authors:  Antonia Serrano; Patricia Rivera; Francisco J Pavon; Juan Decara; Juan Suárez; Fernando Rodriguez de Fonseca; Loren H Parsons
Journal:  Alcohol Clin Exp Res       Date:  2011-12-05       Impact factor: 3.455

2.  Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence.

Authors:  Samuel W Centanni; Bridget D Morris; Joseph R Luchsinger; Gaurav Bedse; Tracy L Fetterly; Sachin Patel; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-11-02       Impact factor: 7.853

3.  Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons.

Authors:  Balapal S Basavarajappa; Ipe Ninan; Ottavio Arancio
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

Review 4.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

5.  Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice.

Authors:  Michelle R Hoot; Laura J Sim-Selley; Justin L Poklis; Rehab A Abdullah; Krista L Scoggins; Dana E Selley; William L Dewey
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

6.  Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis.

Authors:  Won-Mook Choi; Hee-Hoon Kim; Myung-Ho Kim; Resat Cinar; Hyon-Seung Yi; Hyuk Soo Eun; Seok-Hwan Kim; Young Jae Choi; Young-Sun Lee; So Yeon Kim; Wonhyo Seo; Jun-Hee Lee; Young-Ri Shim; Ye Eun Kim; Keungmo Yang; Tom Ryu; Jung Hwan Hwang; Chul-Ho Lee; Hueng-Sik Choi; Bin Gao; Won Kim; Sang Kyum Kim; George Kunos; Won-Il Jeong
Journal:  Cell Metab       Date:  2019-08-29       Impact factor: 27.287

7.  Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol.

Authors:  Matthew J Pava; Emily M Blake; Stephen T Green; Brandon J Mizroch; Patrick J Mulholland; John J Woodward
Journal:  Psychopharmacology (Berl)       Date:  2011-06-24       Impact factor: 4.530

8.  Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol.

Authors:  Marina Rubio; Douglas McHugh; Javier Fernández-Ruiz; Heather Bradshaw; J Michael Walker
Journal:  Neurosci Lett       Date:  2007-06-02       Impact factor: 3.046

Review 9.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

10.  Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse.

Authors:  Sara González; Marta Valenti; Rosario de Miguel; Filomena Fezza; Javier Fernández-Ruiz; Vincenzo Di Marzo; José A Ramos
Journal:  Br J Pharmacol       Date:  2004-09-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.